Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Dendreon
>
Amick will not even put out a PR about this. Fiduciary responsility sir?
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 5244920"]You may disagree, but that is not how the SEC and auditors interpret the word "material". While it is ultimately a judgment call, the general guideline is that if an item impacts less than 5% of a company's revenue or assets then the item is immaterial. As DNDN never publicly forecast that revenues from publicly-reimbursed hospitals in the UK would equal or exceed 5% of total revenues in the next operating cycle (operating cycle is accountant-speak for "one year"), then I think they can wiggle off the hook on this disclosure.</p><p><br /></p><p>Note that the product is approved for sale in the UK, and that has not changed, but the NHS has declined to pay for it at the price requested.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 5244920"]You may disagree, but that is not how the SEC and auditors interpret the word "material". While it is ultimately a judgment call, the general guideline is that if an item impacts less than 5% of a company's revenue or assets then the item is immaterial. As DNDN never publicly forecast that revenues from publicly-reimbursed hospitals in the UK would equal or exceed 5% of total revenues in the next operating cycle (operating cycle is accountant-speak for "one year"), then I think they can wiggle off the hook on this disclosure. Note that the product is approved for sale in the UK, and that has not changed, but the NHS has declined to pay for it at the price requested.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Dendreon
>
Amick will not even put out a PR about this. Fiduciary responsility sir?
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Dendreon
>
Amick will not even put out a PR about this. Fiduciary responsility sir?
>